AKT1 and cancer: PI3K/AKT signaling also promotes the activity of glycolytic enzymes [51, 52] and the upregulation of glucose transporters [53, 54], which helps produce the cellular metabolic shift toward aerobic glycolysis observed in many cancer cells [55].